There’s Always Hope: Myelodysplastic Syndromes (MDS)

William Shomali, MD Research continues to accelerate for myelodysplastic syndromes (MDS), giving hope to patients and their loved ones. In this episode, Dr. William Shomali of Stanford University dives into cutting-edge treatments for both low and high-risk MDS. Learn about the innovative therapies that are enhancing quality of life and explore the promising strides towards curative treatments. Don’t miss this inspiring conversation filled with valuable insights and hope for a brighter future.   DOWNLOAD TRANSCRIPT CLICK HERE to participate in our episode survey. Mentioned on this episode:  Myelodysplastic syndromes (MDS) Acute myeloid leukemia (AML) IPSS-Molecular (IPSS-M) risk stratification Bone marrow transplantation Iron chelation CAR T-cell Therapy Bispecific Antibodies Clinical Trial Support Center Additional LLS Support Resources:  Information Specialists  Free Nutrition Consultations Financial support Free telephone/web patient programs  Free booklets  Young Adult Resources Online chats  Support groups  Caregiver support  Caregiver Workbook Advocacy and Public Policy Survivorship Workbook LLS Community  Mental Health Resources Support for this episode provided by Geron Corporation and Taiho Oncology, Inc.The post There’s Always Hope: Myelodysplastic Syndromes (MDS) first appeared on The Bloodline with Blood Cancer United Podcast.